Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Frontiers in Artificial Intelligence(2022)10.3389/frai.2022.876100Source: DataRank Database

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer is a research paper published in Frontiers in Artificial Intelligence (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.17)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Ranran Wu ORCID,Jody V. Vykoukal ORCID,Eunice Murage ORCID,Rachelle Spencer ORCID,Jennifer B. Dennison ORCID

Live enrichment

PubMed:36034598 PMC:PMC9403735 OpenAlex:https://openalex.org/W4291016560

National Institutes of Health

Grant: 3UL1TR003167-02S4

Center for Clinical and Translational Sciences (CCTS)

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 5R01GM122775-03

Viral miRs and cellular miRs in sepsis

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/frai.2022.876100

publisherhttps://doi.org/10.3389/frai.2022.876100

publisherhttps://www.frontiersin.org/articles/10.3389/frai.2022.876100/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36034598

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9403735

Fields of Study

Epigenetics and DNA MethylationMetabolomics and Mass Spectrometry StudiesMetabolism, Diabetes, and Cancer03 medical and health sciences0302 clinical medicine

Keywords

Triple-negative breast cancerBreast cancerOncologyChemotherapyInternal medicineMedicineBiomarkerCancerBiologyPredictionArtificial intelligenceBiomarkersNeoadjuvant chemotherapyDeep-learning ModelElectronic computers. Computer scienceQA75.5-76.95

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being